PRESS RELEASE - 5 October 2007

SEGF INVESTS A FURTHER £250,000 INTO SYNERMED EUROPE LIMITED

The South East Growth Fund (‘SEGF’), a venture capital fund investing in high growth businesses across the South East region, has made a second round equity investment of £250,000 in Synermed Europe. The funding will enable the company to continue its expansion plans, following the management buyout in April 2006, also supported by SEGF.

Synermed Europe develops and markets clinical chemistry diagnostics systems for both human and veterinary markets.

Avent Bezuidenhoudt, who led the deal for SEGF, is a non-executive director on the Synermed Europe Board. She said: “Since the MBO completed, our belief in Synermed’s unique product offering has continued to grow and with the expansion of the management team to include a new Chairman and Operations Director, the company is well poised to rapidly develop its market position throughout the UK.”

Douglas Evans, Executive Chairman of Synermed Europe, said: “Synermed’s presence in the UK vet-practice market is now well established and at a level from which we can expand with new products and new business models.”